Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective.

Female patients and patients with no insurance, Medicare, or Medicaid are more likely to decline recommended treatment for SCC of the head and neck. Educational status is not predictive of declining treatment.